Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 98

1.

Causes, outcome and prevention of abandonment in retinoblastoma in India.

Kumar A, Moulik NR, Mishra RK, Kumar D.

Pediatr Blood Cancer. 2013 May;60(5):771-5. doi: 10.1002/pbc.24454. Epub 2013 Jan 9.

PMID:
23303533
2.

The clinical spectrum and treatment outcome of retinoblastoma in Indian children.

Shanmugam MP, Biswas J, Gopal L, Sharma T, Nizamuddin SH.

J Pediatr Ophthalmol Strabismus. 2005 Mar-Apr;42(2):75-81; quiz 112-3.

PMID:
15825743
3.

Treatment refusal and abandonment in childhood acute lymphoblastic leukemia in Indonesia: an analysis of causes and consequences.

Sitaresmi MN, Mostert S, Schook RM; Sutaryo., Veerman AJ.

Psychooncology. 2010 Apr;19(4):361-7. doi: 10.1002/pon.1578.

PMID:
19434599
4.

The effect of therapy refusal against medical advice in retinoblastoma patients in a setting where treatment delays are common.

Sitorus RS, Moll AC, Suhardjono S, Simangunsong LS, Riono P, Imhof S, Völker-Dieben HJ.

Ophthalmic Genet. 2009 Mar;30(1):31-6. doi: 10.1080/13816810802464320.

PMID:
19172508
5.

Strategies to manage retinoblastoma in developing countries.

Chantada GL, Qaddoumi I, Canturk S, Khetan V, Ma Z, Kimani K, Yeniad B, Sultan I, Sitorus RS, Tacyildiz N, Abramson DH.

Pediatr Blood Cancer. 2011 Mar;56(3):341-8. doi: 10.1002/pbc.22843. Epub 2010 Nov 11. Review.

PMID:
21225909
6.

Retinoblastoma in Iran: outcomes in terms of patients' survival and globe survival.

Naseripour M, Nazari H, Bakhtiari P, Modarres-zadeh M, Vosough P, Ausari M.

Br J Ophthalmol. 2009 Jan;93(1):28-32. doi: 10.1136/bjo.2008.139410. Epub 2008 Oct 24.

PMID:
18952647
7.

SIOP-PODC recommendations for graduated-intensity treatment of retinoblastoma in developing countries.

Chantada G, Luna-Fineman S, Sitorus RS, Kruger M, Israels T, Leal-Leal C, Bakhshi S, Qaddoumi I, Abramson DH, Doz F; SIOP-PODC Graduated-Intensity Retinoblastoma Guidelines Writing Committee..

Pediatr Blood Cancer. 2013 May;60(5):719-27. doi: 10.1002/pbc.24468. Epub 2013 Jan 17.

PMID:
23335388
8.

Retinoblastoma in Central America: report from the Central American Association of Pediatric Hematology Oncology (AHOPCA).

Luna-Fineman S, Barnoya M, Bonilla M, Fu L, Baez F, Rodríguez-Galindo C.

Pediatr Blood Cancer. 2012 Apr;58(4):545-50. doi: 10.1002/pbc.23307. Epub 2011 Sep 9.

PMID:
21910211
9.

Impact of an education program on late diagnosis of retinoblastoma in Honduras.

Leander C, Fu LC, Peña A, Howard SC, Rodriguez-Galindo C, Wilimas JA, Ribeiro RC, Haik B.

Pediatr Blood Cancer. 2007 Nov;49(6):817-9.

PMID:
17009236
10.

Management of massive orbital involvement of intraocular retinoblastoma.

Kiratli H, Bilgiç S, Ozerdem U.

Ophthalmology. 1998 Feb;105(2):322-6.

PMID:
9479294
11.

Chemoreduction plus focal therapy for retinoblastoma: factors predictive of need for treatment with external beam radiotherapy or enucleation.

Shields CL, Honavar SG, Meadows AT, Shields JA, Demirci H, Singh A, Friedman DL, Naduvilath TJ.

Am J Ophthalmol. 2002 May;133(5):657-64.

PMID:
11992863
12.

Clinical and epidemiological characteristics of retinoblastoma: correlation with prognosis in a Turkish pediatric oncology center.

Ozdemir H, Tacyildiz N, Unal E, Yavuz G, Ugur H, Gunduz K.

Pediatr Hematol Oncol. 2007 Apr-May;24(3):221-31.

PMID:
17454793
13.

A retrospective review of visual outcome and complications in the treatment of retinoblastoma.

O'Doherty M, Lanigan B, Breathnach F, O'Meara A, Gallie B, Chan H, O'Keefe M.

Ir Med J. 2005 Jan;98(1):17-20.

PMID:
15782728
14.

Histopathologic risk factors in retinoblastoma in India.

Gupta R, Vemuganti GK, Reddy VA, Honavar SG.

Arch Pathol Lab Med. 2009 Aug;133(8):1210-4. doi: 10.1043/1543-2165-133.8.1210.

PMID:
19653711
15.

Late presentation of retinoblastoma in Malaysia.

Menon BS, Alagaratnam J, Juraida E, Mohamed M, Ibrahim H, Naing NN.

Pediatr Blood Cancer. 2009 Feb;52(2):215-7. doi: 10.1002/pbc.21791.

PMID:
18855905
16.

Metastatic retinoblastoma clinical features, treatment, and prognosis.

Gündüz K, Müftüoglu O, Günalp I, Unal E, Taçyildiz N.

Ophthalmology. 2006 Sep;113(9):1558-66. Epub 2006 Jul 7.

PMID:
16828510
17.

Clinical presentation and outcome of retinoblastoma among children treated at the National Cancer Institute (NCI) in Gezira, Sudan: a single Institution experience.

Ali AA, Elsheikh SM, Elhaj A, Osman N, Abuidris D, Eltayeb EA, Mahgoub M, Hamdoun A, Babiker MM, Mohamedani AA, Elwali NE, Qaddoumi I.

Ophthalmic Genet. 2011 Jun;32(2):122-5. doi: 10.3109/13816810.2010.546822. Epub 2011 Mar 2.

PMID:
21366428
18.

Clinical characteristics and treatment outcome of children with intraocular retinoblastoma: a report from a Chinese cooperative group.

Gao YJ, Qian J, Yue H, Yuan YF, Xue K, Yao YQ.

Pediatr Blood Cancer. 2011 Dec 15;57(7):1113-6. doi: 10.1002/pbc.23002. Epub 2011 Jun 16.

PMID:
21681922
19.

Compliance in retinoblastoma.

Bakhshi S, Gupta S, Gogia V, Ravindranath Y.

Indian J Pediatr. 2010 May;77(5):535-40. doi: 10.1007/s12098-010-0047-8. Epub 2010 Mar 19.

PMID:
20422323
20.

Treatment of retinoblastoma patients with chemoreduction plus local therapy: experience of the AC Camargo Hospital, Brazil.

Antoneli CB, Ribeiro KC, Steinhorst F, Novaes PE, Chojniak MM, Malogolowkin M.

J Pediatr Hematol Oncol. 2006 Jun;28(6):342-5.

PMID:
16794500

Supplemental Content

Support Center